Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Donald Yin"'
Autor:
Jonathan M Plumb, Mark J Nagy, Robert J. LoCasale, Donald Yin, Sajan Khosla, Ben Gutierrez, Mette Hammer, Chris L Pashos, Michael J Seewald, Maurille Feudjo Tepie, Johan Liwing
Publikováno v:
Journal of Comparative Effectiveness Research. 9:155-159
This White Paper is authored by 11 industry real-world evidence (RWE) experts, with support from IQVIA, as part of the ‘RWE Leadership Forum’: a group of industry leaders who come together as noncompetitive partners to understand and respond to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141a5cf309c5fbed0fc44d245be4f1af
https://doi.org/10.2217/cer-2019-0183
https://doi.org/10.2217/cer-2019-0183
Publikováno v:
Diabetes & Metabolism. 36:198-203
Aims. - The purpose of this study was to investigate the time between the start of OAD treatment and the initiation of insulin therapy and to identify the factors associated with insulin prescription among Swedish patients with type 2 diabetes in Upp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169817eb1abd0b3969bbdca63a90abe4
https://doi.org/10.1016/j.diabet.2009.11.006
https://doi.org/10.1016/j.diabet.2009.11.006
Autor:
G. Nocea, Charles M. Alexander, F. Álvarez Guisasola, Evo Alemao, Donald Yin, Panagiotis Mavros
Publikováno v:
Diabetes, Obesity and Metabolism. 10:8-15
Objective: This study was undertaken to assess glycaemic control as well as changes in glycaemic control over time in patients with type 2 diabetes mellitus (T2DM) who added a sulphonylurea (SU) or thiazolidinedione (TZD) to their metformin monothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902717af84bc4f69a10fbbd8543ead57
https://doi.org/10.1111/j.1463-1326.2008.00881.x
https://doi.org/10.1111/j.1463-1326.2008.00881.x
Publikováno v:
International Journal of Clinical Practice. 62:708-716
AIMS To examine medical resource use of Swedish patients with type 2 diabetes during 2000-2004 and to estimate annual costs of care. METHODS Retrospective population-based cohort study of patients with type 2 diabetes identified in computerised medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80e7bde3501a076c9441272605efdf1
https://doi.org/10.1111/j.1742-1241.2008.01716.x
https://doi.org/10.1111/j.1742-1241.2008.01716.x
Publikováno v:
Clinical Therapeutics. 29:778-794
Background: Previous meta-analyses reported by Gould et al found significant decreases of 15% in the risk for coronary heart disease (CHD)-related mortality and 11 % in risk for all-cause mortality per decrease of 10% in total cholesterol (TC) level.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09364809bd76875ca607aec1fca23a5
https://doi.org/10.1016/j.clinthera.2007.05.012
https://doi.org/10.1016/j.clinthera.2007.05.012
Autor:
G. Nocea, V. Sazonov Kocevar, L. Antonicelli, Donald Yin, L. Laforest, E. Van Ganse, Q. Zhang
Publikováno v:
Respiratory Medicine. 100(1):140-147
Summary Background This study assessed the relationship between asthma burden and asthma severity in France, Italy, and Spain. Methods Adult asthmatics, 18–55 years of age, completed a questionnaire while visiting a respiratory physician in 1998 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6516860102bd8f6f9e7ab963b4a7ae2a
Autor:
Daniel M. Huse, Michele Kohli, Chantal Bourgault, Michael A Marentette, John R. Cook, Annette Lam, Donald Yin, Cheryl L. Attard, Evo Alemao
Publikováno v:
PharmacoEconomics. 24(8):815-830
Introduction: This analysis compared the cost effectiveness of adding ezetimibe to atorvastatin therapy versus atorvastatin titration or adding cholestyramine (a resin) for patients at high risk of a coronary artery disease (CAD) event who did not re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0feece24a93d8df0f93d5ae4caed83
http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200624080-00007.htm
http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200624080-00007.htm
Publikováno v:
Annals of Allergy, Asthma & Immunology. 95:129-136
Asthma and allergic rhinitis are frequently comorbid conditions. Montelukast is effective in treating both diseases and may reduce total medication use among children with asthma and allergic rhinitis.To determine the differences in respiratory and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d8ed0ff7777e0646f4a5b0faace02e
https://doi.org/10.1016/s1081-1206(10)61201-x
https://doi.org/10.1016/s1081-1206(10)61201-x
Autor:
Peter Polos, Jean Bousquet, Donald Yin, S. Gaugris, V. Sazonov Kocevar, Q. Zhang, Leif Bjermer
Publikováno v:
Clinical Experimental Allergy. 35:723-727
Background Inadequately controlled allergic rhinitis (AR) in asthmatic patients can contribute towards increased asthma exacerbations and poorer symptom control, which may increase medical resource use. We assessed asthma-related medical resource use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93cac5f510075aa59639e542c46050f3
https://doi.org/10.1111/j.1365-2222.2005.02251.x
https://doi.org/10.1111/j.1365-2222.2005.02251.x
Autor:
P Le Jeunne, M Bertrand, Donald Yin, Evo Alemao, Philippe Moulin, Noémie Travier, E. Van Ganse, G. de Pouvourville, T. Souchet, L. Laforest
Publikováno v:
British Journal of Clinical Pharmacology. 59:456-463
Background Evidence confirms the positive effects of lipid-lowering agents on the risk of cardiovascular disease. Local guidelines in France (AFSSAPS) have defined therapeutic objectives for LDL-cholesterol. These objectives vary with the number of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf79887c43e05913ffb668ee266daee
https://doi.org/10.1111/j.1365-2125.2005.02266.x
https://doi.org/10.1111/j.1365-2125.2005.02266.x